FINWIRES · TerminalLIVE
FINWIRES

LivaNova's PolySync Algorithm Supports Improvement in Sleep Apnea Treatment Response Rate

By

LivaNova (LIVN) said new data showed its PolySync programming algorithm raised the cumulative response rate to 84.5% in moderate to severe obstructive sleep apnea patients by converting most non-responders after reprogramming.

The findings build on earlier results showing a 65% responder rate after 12 months of therapy delivered by the company's aura6000 system, LivaNova said Tuesday in a statement.

Reprogramming non-responders with simultaneous-contact stimulation significantly improved outcomes and produced no serious adverse events, the company said.

LivaNova plans to file a premarket approval supplement application with the US Food and Drug Administration in H2 for a next-generation device with MRI compatibility and other upgrades.

Price: $80.53, Change: $+0.83, Percent Change: +1.04%

Related Articles